Sino Biopharmaceutical reported CNY0.19 in EPS Earnings Per Share for its fiscal semester ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025H1 Jun/2025 0.19 0.08 Aug/18 2025
FY2024H1 Jun/2024 0.08 0.01 Aug/19 2024
FY2023H2 Dec/2023 0.03 0.10 Mar/28 2024
FY2023H1 Jun/2023 0.01 0.03 Aug/25 2023
FY2022H2 Dec/2022 0.10 0.06 0.09 Mar/31 2023
Jun/2022 0.08 0.10 Nov/28 2022
Jun/2022 0.10 0.10 Aug/23 2022
Mar/2022 0.09 0.10 May/25 2022
Mar/2022 0.12 0.16 0.05 Mar/30 2022
Sep/2021 0.20 -0.53 Nov/30 2021
Jun/2021 0.10 0.35 0.04 Aug/31 2021
Mar/2021 0.10 0.06 -1.61 May/24 2021


Eps Change Date
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
Avita Medical USD -0.21 0.05 Dec/2024
Cspc Pharmaceutical CNY 0.13 0.08 Mar/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Jiangsu Hengrui CNY 0.33 0.03 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Sino Biopharmaceutical CNY 0.19 0.16 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025